Showing results (71-80 of 264) with videos related to
Sort By:
Pageof 27
Allergologie Select|December 6, 2021
Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical reviewKarl-Christian Bergmann, Markus Berger, Ludger Klimek, et al.International Archives of Allergy and Immunology|November 28, 2012
Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparationOliver Pfaar, Esther van Twuijver, Heike Hecker, et al.Clinical and Translational Allergy|January 11, 2025
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approachOliver Pfaar, Anju T Peters, Camille Taillé, et al.Allergologie Select|March 29, 2024
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significanceFelix Klimek, Christoph Bergmann, Jan Hagemann, et al.The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2026
The management of NSAID-ERD patients in the current treatment landscape: aspirin desensitization, biologics, both, or neither?Whitney W Stevens, Irina Bobolea, Joaquim Mullol, et al.Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical ImmunologyOliver Pfaar, Eckard Hamelmann, Ludger Klimek, et al.Allergologie Select|March 1, 2021
Anti-IgE: A treatment option in allergic rhinitis?Oliver Pfaar, Francesca Gehrt, Hansen Li, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 28, 2024
Efficacy of 300 IR house dust mite immunotherapy as a function of disease activity: Tertile analysis in clinical trialsPhilippe Devillier, Pascal Demoly, Catherine Gentil, et al.Clinical and Translational Allergy|August 7, 2014
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparationsLudger Klimek, Annette Sperl, Esther van Twuijver, et al.Clinical and Translational Allergy|July 31, 2014
An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodologyMoises A Calderón, Pablo Rodríguez Del Río, Carmen Vidal, et al.Pageof 27